Currently out of the existing stock ratings of Navin Jacob, 19 are a HOLD (46.34%), 22 are a BUY (53.66%).

Navin Jacob

Work Performance Price Targets & Ratings Chart

Analyst Navin Jacob, currently employed carries an average stock price target met ratio of 70.04% that have a potential upside of 16.15% achieved within 254 days. Previously, Navin Jacob worked at UBS.

Navin Jacob’s has documented 120 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ABBV, AbbVie at 17-Jan-2024.

Wall Street Analyst Navin Jacob

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 11/29/2021. The price target of $267 was fulfilled within 16 days with a profit of $18.89 (7.61%) receiving and performance score of 4.76.

Average potential price target upside

of $31.02 (20.08%) on VRTX (VERTEX PHARMACEUTICALS).
of $22.7 (43.24%) on ICPT (INTERCEPT PHARMACEUTICALS).
of $20 (10.49%) on LLY (ELI LILLY AND COMPANY).

ABBV AbbVie LLY Eli Lilly and Company RPRX Royalty Pharma Plc AGN Allergan plc ICPT Intercept Pharmaceuticals MYL Viatris TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis MRK Merck mpany CELG Celgene REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Christopher Raymond (PIPER SANDLER)